Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20080202518 A1
Publication typeApplication
Application numberUS 11/678,443
Publication dateAug 28, 2008
Filing dateFeb 23, 2007
Priority dateFeb 23, 2007
Publication number11678443, 678443, US 2008/0202518 A1, US 2008/202518 A1, US 20080202518 A1, US 20080202518A1, US 2008202518 A1, US 2008202518A1, US-A1-20080202518, US-A1-2008202518, US2008/0202518A1, US2008/202518A1, US20080202518 A1, US20080202518A1, US2008202518 A1, US2008202518A1
InventorsMichael Paul Mitton, Robert Quinyew Tham, Gary James Choncholas, Jaron Matthew Acker, John Raymond Pinkert
Original AssigneeGeneral Electric Company
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Setting mandatory mechanical ventilation parameters based on patient physiology
US 20080202518 A1
Abstract
A method of setting expiratory time in controlled mechanical ventilation sets a subject's expiratory time based on when the subject's natural exhalation flow ceases. Another method determines when the subject's natural exhalation flow ceases and sets the subject's expiratory time based on the determination. A device for use in controlled mechanical ventilation comprises a flow rate sensor configured to determine when a subject's natural exhalation flow ceases and bases the subject's expiratory time on the determination.
Images(8)
Previous page
Next page
Claims(18)
1. A method of setting expiratory time in controlled mechanical ventilation, comprising:
setting a subject's expiratory time based on when said subject's natural exhalation flow ceases.
2. A method of setting expiratory time in controlled mechanical ventilation, comprising:
determining when a subject's natural exhalation flow ceases; and
setting said subject's expiratory time based on said determination.
3. The method of claim 2, wherein said expiratory time is set equal to when said natural exhalation flow ceases.
4. The method of claim 2, wherein said expiratory time is set substantially equal to when said natural exhalation flow ceases.
5. The method of claim 2, wherein said expiratory time is set greater than or equal to when said natural exhalation flow ceases.
6. The method of claim 2, wherein said determination is based, at least in part, on a flow rate sensor.
7. The method of claim 6, wherein said flow rate sensor is selected from a group consisting of a spirometer, anemometer, thermal anemometer, pneumotachometer, and ultrasound flow sensor.
8. The method of claim 6, wherein said flow rate sensor determines said subject's breathing gas flow rate.
9. The method of claim 2, wherein said determination is based, at least in part, on effects of gas movement in said subject's airways.
10. The method of claim 9, wherein said effects are determined, at least in part, by one or more of the following:
acoustic analysis of said subject;
vibration analysis of said subject;
airway pressure analysis of said subject;
capnographic morphology analysis of said subject; and
respiratory mechanics analysis of said subject.
11. The method of claim 2, wherein said determination is based, at least in part, on thoracic excursion of said subject corresponding to said subject's lung volume.
12. The method of claim 11, wherein said thoracic excursion comprises one or more of the following:
imaging said subject;
plethysmographic analysis of said subject; and
electrical impedance tomography analysis of said subject.
13. The method of claim 2, further comprising:
displaying at least one or more of when said natural exhalation flow ceases or said expiratory time or both on a monitor.
14. The method of claim 13, wherein said monitor is at least one of a handheld or portable device or both.
15. A device use in controlled mechanical ventilation, comprising:
a flow rate sensor configured to determine when a subject's natural exhalation flow ceases and base said subject's expiratory time on said determination.
16. The device of claim 15, wherein said flow rate sensor is selected from a group consisting of a spirometer, anemometer, thermal anemometer, pneumotachometer, and ultrasound flow sensor.
17. The device of claim 15, wherein said flow rate sensor determines said subject's breathing gas flow rate.
18. The device of claim 15, further comprising:
circuitry operable in conjunction with said flow rate sensor configured to set said expiratory time based on said determination.
Description
    FIELD OF INVENTION
  • [0001]
    In general, the inventive arrangements relate to respiratory care, and more specifically, to improvements in controlling mandatory mechanical ventilation.
  • BACKGROUND OF INVENTION
  • [0002]
    Referring generally, when patients are medically unable to breathe on their own, mechanical, or forced, ventilators can sustain life by providing requisite pulmonary gas exchanges on behalf of the patients. Accordingly, modern ventilators usually include electronic and pneumatic control systems that control the pressure, flow rates, and/or volume of gases delivered to, and extracted from, patients needing medical respiratory assistance. Oftentimes, such control systems include a variety of knobs, dials, switches, and the like, for interfacing with treating clinicians, who support the patient's breathing by adjusting the afore-mentioned pressure, flow rates, and/or volume of the patient's pulmonary gas exchanges, particularly as the condition and/or status of the patient changes. Even today, however, such parameter adjustments, although highly desirable, remain challenging to control accurately, particularly using present-day arrangements and practices.
  • [0003]
    Referring now more specifically, ventilation is a complex process of delivering oxygen to, and removing carbon dioxide from, alveoli within patients' lungs. Thus, whenever a patient is ventilated, that patient becomes part of a complex, interactive system that is expected to promote adequate ventilation and gas exchange on behalf of the patient, eventually leading to the patient's stabilization, recovery, and ultimate ability to return to breathing normally and independently.
  • [0004]
    Not surprisingly, a wide variety of mechanical ventilators are available today. Most allow their operating clinicians to select and use several modes of ventilation, either individually and/or in various combinations, using various ventilator setting controls.
  • [0005]
    These mechanical ventilation modes are generally classified into one (1) of two (2) broad categories: a) patient-triggered ventilation, and b) machine-triggered ventilation, the latter of which is also commonly referred to as controlled mechanical ventilation (CMV). In patient-triggered ventilation, the patient determines some or all of the timing of the ventilation parameters, while in CMV, the operating clinician determines all of the timing of the ventilation parameters. Notably, the inventive arrangements described hereinout will be particularly relevant to CMV.
  • [0006]
    In recent years, mechanical ventilators have become increasingly sophisticated and complex, due, in large part, to recently-enhanced understandings of lung pathophysiology. Technology also continues to play a vital role. For example, many modern ventilators are now microprocessor-based and equipped with sensors that monitor patient pressure, flow rates, and/or volumes of gases, and then drive automated responses in response thereto. As a result, the ability to accurately sense and transduce, combined with computer technology, makes the interaction between clinicians, ventilators, and patients more effective than ever before.
  • [0007]
    Unfortunately, however, as ventilators become more complicated and offer more options, the number and risk of potentially dangerous clinical decisions increases as well. Thus, clinicians are often faced with expensive, sophisticated machines, yet few follow clear, concise, and/or consistent guidelines for maximal use thereof. As a result, setting, monitoring, and interpreting ventilator parameters can devolve into empirical judgment, leading to less than optimal treatment, even by well-intended practitioners.
  • [0008]
    Complicating matters ever further, ventilator support should be individually tailored for each patient's existing pathophysiology, rather than deploying a generalized approach for all patients with potentially disparate ventilation needs.
  • [0009]
    Pragmatically, the overall effectiveness of assisted ventilation will continue to, ultimately depend on mechanical, technical, and physiological factors, with the clinician-ventilator-patient interface invariably continuing to play a key role. Accordingly, technology that demystifies these complex interactions and provides appropriate information to effectively ventilate patients is needed.
  • [0010]
    In accordance with the foregoing, it remains desirable to provide maximally effective mechanical ventilation parameters, particularly engaging clinicians to supply appropriate quantities and qualities of ventilator support to patients, customized for each individual patient's particular ventilated pathophysiology.
  • SUMMARY OF INVENTION
  • [0011]
    In one embodiment, a method of setting expiratory time in controlled mechanical ventilation comprises setting a subject's expiratory time based on when the subject's natural exhalation flow ceases.
  • [0012]
    In another embodiment, a method of setting expiratory time in controlled mechanical ventilation comprises determining when a subject's natural exhalation flow ceases and setting said subject's expiratory time based on said determination.
  • [0013]
    In yet another embodiment, a device for use in controlled mechanical ventilation comprises a flow rate sensor configured to determine when a subject's natural exhalation flow ceases and base the subject's expiratory time on the determination.
  • BRIEF DESCRIPTION OF SEVERAL VIEWS OF THE DRAWINGS
  • [0014]
    A clear conception of the advantages and features constituting inventive arrangements, and of various construction and operational aspects of typical mechanisms provided by such arrangements, are readily apparent by referring to the following illustrative, exemplary, representative, and/or non-limiting figures, which form an integral part of this specification, in which like numerals generally designate the same elements in the several views, and in which:
  • [0015]
    FIG. 1 depicts a front perspective view of a medical system comprising a ventilator;
  • [0016]
    FIG. 2 depict\s a block diagram of a medical system providing ventilator support to a patient;
  • [0017]
    FIG. 3 depicts a block diagram of a ventilator providing ventilator support to the patient;
  • [0018]
    FIG. 4 depicts a flow diagram of the patient's inspiratory time (TI), expiratory time (TE), and natural exhalation time (TEXH) for a single breath, particularly during controlled mechanical ventilation (CMV);
  • [0019]
    FIG. 5 depicts a flowchart of a simplified arrangement for setting the patient's expiratory time (TE) based on the patient's natural exhalation time (TEXH);
  • [0020]
    FIG. 6 depicts a flowchart of a simplified arrangement for setting the patient's expiratory time (TE) based on when the patient's natural exhalation flow ceases;
  • [0021]
    FIG. 7 depicts a flowchart of a simplified arrangement for setting the patient's expiratory time (TE) based on when the patient's tidal volume has expired;
  • [0022]
    FIG. 8 depicts a response curve of the patient's delivered inspiratory time (dTI) and exhaled CO2 levels (FETCO2);
  • [0023]
    FIG. 9 depicts the delivered inspiratory time (dTI) response curve of FIG. 8, graphically depicting an arrangement to identify the patient's optimal inspiratory time (TI-OPTIMAL); and
  • [0024]
    FIG. 10 depicts a response curve of the patient's delivered inspiratory time (dTI) and exhaled VCO2 levels.
  • DETAILED DESCRIPTION OF VARIOUS PREFERRED EMBODIMENTS
  • [0025]
    Referring now to the figures, and in particular to FIGS. 1-3, a medical system 10 is depicted for mechanically ventilating a patient 12. More specifically, an anesthesia machine 14 includes a ventilator 16, the latter having suitable connectors 18, 20 for connecting to an inspiratory branch 22 and expiratory branch 24 of a breathing circuit 26 leading to the patient 12. As will be subsequently elaborated upon, the ventilator 16 and breathing circuit 26 cooperate to provide breathing gases to the patient 12 via the inspiratory branch 22 and to receive gases expired by the patient 12 via the expiratory branch 24.
  • [0026]
    If desired, the ventilator 16 can also be provided with a bag 28 for manually bagging the patient 12. More specifically, the bag 28 can be filled with breathing gases and manually squeezed by a clinician (not shown) to provide appropriate breathing gases to the patient 12. Using this bag 28, or “bagging the patient,” is often required and/or preferred by the clinicians, as it can enable them to manually and/or immediately control delivery of the breathing gases to the patient 12. Equally important, the clinician can sense conditions in the respiration and/or lungs 30 of the patient 12 according to the feel of the bag 28, and then accommodate for the same. While it can be difficult to accurately obtain this feedback while mechanically ventilating the patient 12 using the ventilator 16, it can also fatigue the clinician if the clinician is forced to bag the patient 12 for too long a period of time. Thus, the ventilator 16 can also provide a toggle 32 for switching and/or alternating between manual and automated ventilation.
  • [0027]
    In any event, the ventilator 16 can also receive inputs from sensors 34 associated with the patient 12 and/or ventilator 16 at a processing terminal 36 for subsequent processing thereof, and which can be displayed on a monitor 38, which can be provided by the medical system 10 and/or the like. Representative data received from the sensors 34 can include, for example, inspiratory time (TI), expiratory time (TE), natural exhalation time (TEXH), respiratory rates (f), I:E ratios, positive end expiratory pressure (PEEP), fractional inspired oxygen (FIO2), fractional expired oxygen (FEO2), breathing gas flow (F), tidal volumes (VT), temperatures (T), airway pressures (Paw), arterial blood oxygen saturation levels (SaO2), blood pressure information (BP), pulse rates (PR), pulse oximetry levels (SpO2), exhaled CO2 levels (FETCO2), concentration of inspired inhalation anesthetic agent (CI agent), concentration of expired inhalation anesthetic agent (CE agent), arterial blood oxygen partial pressure (PaO2), arterial carbon dioxide partial pressure (PaCO2), and the like.
  • [0028]
    Referring now more specifically to FIG. 2, the ventilator 16 provides breathing gases to the patient 12 via the breathing circuit 26. Accordingly, the breathing circuit 26 typically includes the afore-mentioned inspiratory branch 22 and expiratory branch 24. Commonly, one end of each of the inspiratory branch 22 and expiratory branch 24 is connected to the ventilator 16, while the other ends thereof are usually connected to a Y-connector 40, which can then connect to the patient 12 through a patient branch 42, which can also include an interface 43 to secure the patient's 12 airways to the breathing circuit 26 and/or prevent gas leakage out thereof.
  • [0029]
    Referring now more specifically to FIG. 3, the ventilator 16 can also include electronic control circuitry 44 and/or pneumatic circuitry 46. More specifically, various pneumatic elements of the pneumatic circuitry 46 provide breathing gases to the lungs 30 of the patient 12 through the inspiratory branch 22 of the breathing circuit 26 during inhalation. Upon exhalation, the breathing gases are discharged from the lungs 30 of the patient 12 and into the expiratory branch 24 of the breathing circuit 26. This process can be iteratively enabled by the electronic control circuitry 44 and/or pneumatic circuitry 46 in the ventilator 16, which can establish various control parameters, such as the number of breaths per minute to administer to the patient 12, tidal volumes (VT), maximum pressures, etc., that can characterize the mechanical ventilation that the ventilator 16 supplies to the patient 12. As such, the ventilator 16 may be microprocessor based and operable in conjunction with a suitable memory to control the pulmonary gas exchanges in the breathing circuit 26 connected to, and between, the patient 12 and ventilator 16.
  • [0030]
    Even more specifically, the various pneumatic elements of the pneumatic circuitry 46 usually comprise a source of pressurized gas (not shown), which can operate through a gas concentration subsystem (not shown) to provide the breathing gases to the lungs 30 of the patient 12. This pneumatic circuitry 46 may provide the breathing gases directly to the lungs 30 of the patient 12, as typical in a chronic and/or critical care application, or it may provide a driving gas to compress a bellows 48 (see FIG. 1) containing the breathing gases, which can, in turn, supply the breathing gases to the lungs 30 of the patient 12, as typical in an anesthesia application. In either event, the breathing gases iteratively pass from the inspiratory branch 22 to the Y-connector 40 and to the patient 12, and then back to the ventilator 16 via the Y-connector 40 and expiratory branch 24.
  • [0031]
    In the embodiment depicted in FIG. 3, one or more of the sensors 34, placed in the breathing circuit 26, can also provide feedback signals back to the electronic control circuitry 44 of the ventilator 16, particularly via a feedback loop 52. More specifically, a signal in the feedback loop 52 could be proportional, for example, to gas flows and/or airway pressures in the patient branch 42 leading to the lungs 30 of the patient 12. Inhaled and exhaled gas concentrations (such as, for example, oxygen O2, carbon dioxide CO2, nitrous oxide N2O, and inhalation anesthetic agents), flow rates (including, for example, spirometry), and gas pressurization levels, etc., are also representative feedback signals that could be captured by the sensors 34, as can the time periods between when the ventilator 16 permits the patient 12 to inhale and exhale, as well as when the patient's 12 natural inspiratory and expiratory flows cease.
  • [0032]
    Accordingly, the electronic control circuitry 44 of the ventilator 16 can also control displaying numerical and/or graphical information from the breathing circuit 26 on the monitor 38 of the medical system 10 (see FIG. 1), as well as other patient 12 and/or system 10 parameters from other sensors 34 and/or the processing terminal 36 (see FIG. 1). In other embodiments, various components of which can also be integrated and/or separated, as needed and/or desired.
  • [0033]
    By techniques known in the art, the electronic control circuitry 44 can also coordinate and/or control, among other things, for example, other ventilator setting signals 54, ventilator control signals 56, and/or a processing subsystem 58, such as for receiving and processing signals, such as from the sensors 34, display signals for the monitor 38 and/or the like, alarms 60, and/or an operator interface 62, which can include one or more input devices 64, etc., all as needed and/or desired and interconnected appropriately (e.g., see FIG. 2). These components are functionally depicted for clarity, wherein various ones thereof can also be integrated and/or separated, as needed and/or desired. For further enhanced clarity, other functional components should also be well-understood but are not shown—e.g., one or more power supplies for the medical system 10 and/or anesthesia machine 14 and/or ventilator 16, etc. (not shown).
  • [0034]
    Now then, against this background, the inventive arrangements establish ventilation parameters according to patient physiology. These arrangements, to be now described, allow clinicians to control patient ventilation parameters throughout the patient's 12 respiratory cycle and enables ventilation treatments to be individually optimized for patients 12 subject to controlled mechanical ventilation (CMV).
  • [0035]
    To facilitate the following discussion, the following generalized and/or representative explanations and/or definitions may be referred to:
  • [0036]
    1. TI is Inspiratory Time.
  • [0037]
    More specifically, TI is the amount of time, measured in seconds, set on the ventilator 16 by the clinician, lasting from the beginning of the patient's 12 inspiration to the beginning of the patient's 12 expiration. Accordingly, TI is the patient's 12 inspiratory time.
  • [0038]
    Inspiratory times TI can be further broken down into a set inspiratory time sTI, a delivered inspiratory time dTI, and a measured inspiratory time mTI. More specifically, the set inspiratory time sTI is the amount of time that the clinician sets on the ventilator 16 to deliver gases to the patient 12 during inspiration, while the delivered inspiratory time dTI is the amount of time that gases are actually allowed to be delivered to the patient 12 from the ventilator 16, during inspiration. Similarly, the measured inspiratory time mTI is the amount of time that the ventilator 16 measures for allowing gases to be delivered to the patient 12 during inspiration. Ideally, the set inspiratory time sTI, delivered inspiratory time dTI, and measured inspiratory time mTI are equal or substantially equal. However, if the clinician or ventilator 16 is searching for an optimal inspiratory time TI-OPTIMAL as elaborated upon below, then each of these inspiratory times TI may be different or slightly different. For example, the clinician and/or ventilator 16 may have established a set inspiratory time sTI, yet the delivered inspiratory time dTI may deviate therefrom in the process of searching for, for example, the patient's 12 optimal inspiratory time TI-OPTIMAL.
  • [0039]
    2. TE is Expiratory Time.
  • [0040]
    More specifically, TE is the amount of time, measured in seconds, set on the ventilator 16 by the clinician, lasting from the beginning of the patient's 12 expiration to the beginning of the patient's 12 inspiration. Accordingly, TE is the patient's 12 expiratory time.
  • [0041]
    Like inspiratory times TI, expiratory times TE can also be further broken down into a set expiratory time sTE, a delivered expiratory time dTE, and a measured expiratory time mTE. More specifically, the set expiratory time sTE is the amount of time that the clinician sets on the ventilator 16 to allow the patient 12 to exhale gases during expiration, while the delivered expiratory time dTE is the amount of time that gases are allowed to be exhaled by the patient 12 during expiration. Similarly, the measured expiratory time mTE is the amount of time that the ventilator 16 measures for having allowed the patient 12 to exhale gases during expiration. Ideally, the set expiratory time sTE, delivered expiratory time dTE, and measured expiratory time mTE are equal or substantially equal. However, if the clinician or ventilator 16 is searching for an optimal expiratory time TE, as elaborated upon below, then each of these expiratory times TE may be different or slightly different. For example, the clinician and/or ventilator 16 may have established a set expiratory time sTE, yet the delivered expiratory time dTE may deviate therefrom in the process of searching, for example, for the patient's 12 natural exhalation time TEXH.
  • [0042]
    3. I:E Ratios are Ratios Between TI and TE.
  • [0043]
    More specifically, I:E ratios measure inspiratory times divided by expiratory times—i.e., TI/TE, which is commonly expressed as a ratio. Common I:E ratios are 1:2, meaning patients 12 may inhale for a certain period of time () and then exhale for twice as long (2). However, since some patients 12 may have obstructed pathologies (e.g., chronic obstructive pulmonary disease (COPD)) and/or slower exhalation, requiring the clinician to set longer expiratory times TE, I:E ratios can also be set at ratios closer to 1:3 and/or 1:4, particularly to provide the necessary expiratory time TE for a given patient 12 to fully exhale, although I:E ratios from 1:8 and 2:1 are also not uncommon, with common ventilators 16 providing 0.5 gradations therebetween.
  • [0044]
    4. TEXH is Natural Exhalation Time.
  • [0045]
    More specifically, TEXH is the amount of time, measured in seconds, required for the patient's 12 natural exhalation flow to cease. Accordingly, TEXH is the patient's 12 natural exhalation time.
  • [0046]
    Oftentimes, the patient's 12 expiratory time TE does not equal the patient's 12 natural exhalation time TEXH—i.e., the patient's 12 expiratory time TE, as set by the clinician on the ventilator 16, often does not coincide with the patient's 12 natural exhalation time TEXH. Moreover, in accordance with many default settings on many ventilators 16, respiratory rates f (see below) are commonly set between 6-10 breaths/minute and I:E ratios are commonly set at 1:2, resulting in many clinicians setting expiratory times TE between 4.0-6.6 seconds, as opposed to typical natural exhalation times TEXH being less than or equal to approximately 0.8-1.5 seconds. Several of the inventive arrangements, on the other hand, set the patient's 12 expiratory times TE approximately equal to the patient's 12 natural exhalation times TEXH (i.e., 2*TEHX≧TE≧TEXH).
  • [0047]
    If the clinician or ventilator 16 sets the patient's 12 expiratory time TE less than or equal to the patient's 12 natural exhalation time TEXH, there can be inadequate time for the patient 12 to expel the gases in the patient's 12 lungs 30. This can result in stacking breaths in the patient's 12 lungs 30 (i.e., so-called “breath stacking”), thereby inadvertently and/or unknowingly elevating the patient's 12 lung pressure. Accordingly, several of the inventive arrangements set the patient's 12 expiratory time TE approximately equal to the patient's 12 natural exhalation time TEXH, preferably with the patient's 12 expiratory time TE being set greater than or equal to the patient's 12 natural exhalation time TEXH.
  • [0048]
    5. PEEP is Positive End Expiratory Pressure.
  • [0049]
    More specifically, PEEP is the patient's 12 positive end expiratory pressure, often measured in cmH20. Accordingly, PEEP is the amount of pressure in the patient's 12 lungs 30 at the end of the patient's 12 expiratory time TE, as controlled by the ventilator 16.
  • [0050]
    Like inspiratory times TI and expiratory times TE, positive end expiratory pressure PEEP can also be further broken down into a set positive end expiratory pressure sPEEP, a measured positive end expiratory pressure mPEEP, and a delivered positive end expiratory pressure dPEEP. More specifically, the set positive end expiratory pressure sPEEP is the amount of pressure that the clinician sets on the ventilator 16 for the patient 12, while the measured positive end expiratory pressure mPEEP is the amount of pressure in the patient's 12 lungs 30 at the end of the patient's 12 expiratory time TE. Similarly, the delivered positive end expiratory pressure dPEEP is the amount of pressure delivered by the ventilator to the patient 12. Usually, the set positive end expiratory pressure sPEEP, measured positive end expiratory pressure mPEEP, and delivered positive end expiratory pressure dPEEP are equal or substantially equal. However, the measured positive end expiratory pressure mPEEP can be greater than the set positive end expiratory pressure sPEEP when breath stacking, for example, occurs.
  • [0051]
    6. FI02 is Fraction of Inspired Oxygen.
  • [0052]
    More specifically, FI02 is the concentration of oxygen in the patient's 12 inspiratory gas, often expressed as a fraction or percentage. Accordingly, FI02 is the patient's 12 fraction of inspired oxygen.
  • [0053]
    7. FE02 is Fraction of Expired Oxygen.
  • [0054]
    More specifically, FE02 is the concentration of oxygen in the patient's 12 expiratory gas, often expressed as a fraction or percentage. Accordingly, FE02 is the patient's 12 fraction of expired oxygen.
  • [0055]
    8. f is Respiratory Rate.
  • [0056]
    More specifically, f is the patient's 12 respiratory rate, measured in breaths/minute, set on the ventilator 16 by the clinician.
  • [0057]
    9. VT is Tidal Volume.
  • [0058]
    More specifically, VT is the total volume of gases, measured in milliliters, delivered to the patient's 12 lungs 30 during inspiration. Accordingly, VT is the patient's 12 tidal volume.
  • [0059]
    Like inspiratory times TI and expiratory times TE, tidal volumes VT can also be further broken down into a set tidal volume sVT, a delivered tidal volume dVT, and a measured tidal volume mVT. More specifically, the set tidal volume sVT is the volume of gases that the clinician sets on the ventilator 16 to deliver gases to the patient 12 during inspiration, while the delivered tidal volume dVT is the volume of gases actually delivered to the patient 12 from the ventilator 16 during inspiration. Similarly, the measured tidal volume mVT is the volume of gases that the ventilator 16 measures for having delivered gases to the patient 12 during inspiration. Ideally, the set tidal volume sVT, delivered tidal volume dVT, and measured tidal volume mVT are equal or substantially equal. However, if the clinician or ventilator 16 is searching for a set optimal tidal volume sVT, as elaborated upon below, then each of these set tidal volumes sVT may be different or slightly different.
  • [0060]
    10. FETCO2 is End Tidal Carbon Dioxide CO2.
  • [0061]
    More specifically, FETCO2 is the concentration of carbon dioxide CO2 in the patient's 12 exhaled gas, often expressed as a fraction or percentage. Accordingly, FETCO2 is the amount of carbon dioxide CO2 exhaled by the patient 12 at the end of a given breath.
  • [0062]
    11. VCO2 is the Volume of Carbon Dioxide CO2 Per Breath.
  • [0063]
    More specifically, VCO2 is the volume of carbon dioxide CO2 that the patient 12 exhales in a single breath. Accordingly, VCO2 is the patient's 12 volume of CO2 exhaled per breath.
  • [0064]
    Now then, clinicians usually begin ventilation by selecting an initial set tidal volume sVT, respiratory rate f, and I:E ratio. The respiratory rate f and I:E ratio usually determine the initial set inspiratory time sTI and initial set expiratory time sTE that the clinician sets on the ventilator 16. In other words, the actual set inspiratory time sTI and actual set expiratory time sTE that the clinician uses are usually determined in accordance with the following equations:
  • [0000]
    f = 60 sT I + sT E I : E = sT I sT E
  • [0065]
    Moreover, the clinician usually makes these initial determinations based on generic rule-of-thumb settings, taking into account factors such as, for example, the patient's 12 age, weight, height, gender, geographical location, etc. Once the clinician makes these initial determinations, the inventive arrangements can now be appreciated.
  • [0066]
    Referring now to FIG. 4, a graph of the relation between delivered inspiratory time dTI, delivered expiratory time dTE, and natural exhalation time TEXH is depicted for a single breathing cycle for a patient 12 undergoing controlled mechanical ventilation (CMV). As can be seen in the figure, the patient's 12 delivered expiratory time dTE is greater than the patient's 12 natural exhalation time TEXH as can be viewed by the measured expiratory time mTe.
  • [0067]
    Referring now to FIG. 5, a flowchart depicts a simplied arrangement for setting the patient's 12 set expiratory time sTE based on the patient's 12 natural exhalation time TEXH. More specifically, a method begins in a step 100, during which the patient's 12 natural exhalation time TEXH is determined. Preferably, the patient's 12 natural exhalation time TEXH is determined using the patient's 12 airway flow waveform, particularly when the first derivative thereof approaches zero, as is well-known in the art. Alternatively, other arrangements are also well-known in the art and can also be used to determine the patient's 12 natural exhalation time TEXH in step 100, such as, for example, airway flow analysis of the patient 12; tidal volume VT analysis of the patient 12; acoustic analysis of the patient 12; vibration analysis of the patient 12; airway pressure analysis Paw of the patient 12; capnographic morphology analysis of the patient 12; respiratory mechanics analysis of the patient 12; and/or thoracic excursion corresponding to gases exhaled from the lungs 30 of the patient 12 (e.g., imaging the patient 12, plethysmographic analysis of the patient 12, and/or electrical impedance tomography analysis of the patient, and/or the like), etc.
  • [0068]
    Thereafter, the patient's 12 natural exhalation time TEXH can be used to set the patient's 12 set expiratory time sTE on the ventilator 16. More specifically, the patient's 12 set expiratory time sTE can be set based on the patient's 12 natural exhalation time TEXH, and, for example, set equal or substantively equal to the patient's 12 natural exhalation time TEXH, as shown in a step 102 in FIG. 5, after which the method ends.
  • [0069]
    Now then, in accordance with the foregoing, the patient's 12 set expiratory time sTE is preferably set equal to, or slightly greater than, the patient's 12 natural exhalation time TEXH.
  • [0070]
    If, however, the patient's 12 natural exhalation flow does not cease at the end of the patient's 12 ventilated set expiratory time sTE, as set by the clinician and/or ventilator, then the clinician can increase the patient's 12 set expiratory time sTE until the patient's 12 natural exhalation flow ceases.
  • [0071]
    As previously noted, the patient's 12 spontaneous breathing is controlled by numerous reflexes that control the patient's 12 respiratory rates f and tidal volumes VT. Particularly during controlled mechanical ventilation (CMV), however, these reflexes are either obtunded and/or overwhelmed. In fact, one of the only aspects of ventilation that usually remains under the patient's 12 control is the patient's 12 natural exhalation time TEXH, as required for a given volume, as previously elaborated upon. This is why it can be used to set the patient's 12 set expiratory time sTE on the ventilator 16 based thereon.
  • [0072]
    Now then, the inventive arrangements utilize the patient's 12 natural exhalation time TEXH and/or physiological parameters to determine and/or set the patient's 12 set expiratory time sTE, set inspiratory time sTI, and/or set tidal volume sVT, either directly and/or indirectly. For example, the patient's 12 inspiratory time TI may be set directly, or may it be determined by the respiratory rate f for a specific set expiratory time sTE. Likewise, the patient's 12 set tidal volume sVT may also be set directly, or it may be determined by adjusting the patient's 12 inspiratory pressure (PINSP) in, for example, pressure control ventilation (PCV). Adding the patient's 12 set inspiratory time sTI to the patient's 12 set expiratory time sTE results in a breath time that, when divided from 60 seconds, produces the patient's 12 respiratory rate f. Accordingly, the patient's 12 set inspiration time sTI, set expiration time sTE, and respiratory rate f may not be whole numbers.
  • [0073]
    Referring now to FIG. 6, a flowchart depicts a simplied arrangement for setting the patient's 12 set expiratory time sTE based on when the patient's 12 natural exhalation flow ceases. More specifically, a method begins in a step 104, during which the patient's 12 natural exhalation flow cessation is determined. Preferably, the patient's 12 natural exhalation flow cessation is determined using the patient's 12 airway flow waveform, particularly when the first derivative thereof approaches zero, as is well-known in the art. Alternatively, other arrangements are also well-known in the art and can also be used to determine when the patient's 12 natural exhalation flow ceases.
  • [0074]
    Thereafter, the patient's 12 cessation of natural exhalation flow can be used to set the patient's 12 set expiratory time sTE on the ventilator 16. More specifically, the patient's 12 set expiratory time sTE can be set based on the patient's 12 cessation of natural exhalation flow, and, for example, set equal or substantively equal to when the patient's 12 natural exhalation flow ceases, as shown in a step 106 in FIG. 6, after which the method ends.
  • [0075]
    Referring now to FIG. 7, a flowchart depicts a simplied arrangement for setting the patient's 12 set expiratory time sTE based on when the patient's 12 tidal volume VT expires. More specifically, a method begins in a step 108, during which expiration of the patient's 12 tidal volume VT is determined. Preferably, the patient's 12 expiration of tidal volume VT is determined using a flow sensor. Alternatively, other arrangements are also well-known in the art and can also be used to determine when the patient's 12 tidal volume VT expires.
  • [0076]
    Thereafter, the patient's 12 expiration of tidal volume VT can be used to set the patient's 12 set expiratory time sTE on the ventilator 16. More specifically, the patient's 12 set expiratory time sTE can be set based on the patient's 12 expiration of tidal volume VT, and, for example, set equal or substantively equal to when the patient's 12 tidal volume VT expires, as shown in a step 110 in FIG. 7, after which the method ends.
  • [0077]
    As previously indicated,
  • [0000]
    f = 60 sT I + sT E I : E = sT I sT E
  • [0000]
    whereby knowing the patient's 12 respiratory rate f and I:E ratio allows determining the patient's 12 set inspiratory time sTI and set expiratory time sTE, while knowing the patient's 12 set inspiratory time sTI and set expiratory time sTE conversely allows determining the patient's 12 respiratory rate f and I:E ratio. Preferably, the clinician and/or the ventilator sets the patient's 12 respiratory rate f and set expiratory time sTE, for which the patient's 12 set inspiratory time sTI and I:E ratio can then be determined using the above equations.
  • [0078]
    While various mandatory mechanical ventilation modes can be used with the inventive techniques, volume guaranteed pressure control ventilation (i.e., PCV-VG), in particular, will be further described below as a representative example, as it has a decelerating flow profile based on the patient's natural exhalation in response to the ventilator delivered inspiratory pressure, and the set tidal volume sVT is guaranteed by the ventilator on a breath-to-breath basis. However, the inventive arrangements are also equally applicable to other pressure control ventilation (PCV) and/or other ventilator control ventilation (VCV) ventilator modes. In any event, several of the primary control settings on a typical ventilator 16 include controls for one or more of the following: set expiratory time sTE, set inspiratory time sTI, set tidal volumes sVT, and/or fraction of inspired oxygen FIO2.
  • [0079]
    Now then, according to the patient's 12 physiological measurements in a steady state condition:
  • [0000]

    VĊO2 =F ETCO2 *MV A
  • [0000]
    wherein VĊO2 is the volume of C02 per minute exhaled by the patient 12 and MV is the minute volume, which is a total volume exhaled per minute by the patient 12. As used in these expressions, a subscripted A indicates “alveolar,” which is a part of the patient's 12 lungs 30 that participate in gas exchanges with the patient's 12 blood, in contrast to deadspace (VD), such as the patient's 12 airway.
  • [0080]
    In this steady state condition and over a short duration, the patient's 12 blood reservoir is such that VĊO2 is a constant (blood reservoir effects will be elaborated upon below), and, in accordance with this equation, as MVA increases, the patient's 12 end tidal carbon dioxide FETCO2 decreases for a constant VĊO2. Accordingly, substituting MVA=VA*f yields the following:
  • [0000]
    V C . O 2 = F ET CO 2 * V A * f = F ET CO 2 * V A * 60 dT I + dT E V T = V A + V D
  • [0081]
    Accordingly, the same VĊO2 can be achieved by increasing the patient's 12 VA and/or decreasing the patient's 12 respiratory rate f. Decreasing the patient's 12 respiratory rate f has the same effect as increasing the patient's 12 delivered inspiratory time dTI on the ventilator 16. In fact, numerous respiratory rate f and delivered inspiratory time dTI combinations can result in equivalent or nearly equivalent VĊO2 production. Accordingly, an optional combination is desired.
  • [0082]
    As previously described, the patient's 12 natural exhalation time TEXH measures the time period when the patient's 12 natural expiratory gas flow ceases during mechanical ventilation—i.e., the patient's 12 natural exhalation time TEXH comprises the duration of gas flow during the patient's 12 delivered expiratory time dTE. A cessation of flow indicates that the patient's 12 lungs 30 are at their end expiratory lung volume (EELV). Continued gas exchange beyond EELV could become less efficient, largely as a result of the decreased volume of gases in the patient's 12 lungs 30 leading to reduced gas exchange gradient between the lung and the blood. As a result, initiating a new inspiration (i.e., the patient 12 starts a new breath) can be more efficient.
  • [0083]
    Referring now to FIG. 8, the clinician can also increase or decrease the patient's 12 set inspiratory time sTI on the ventilator 16 until the patient's 12 resulting end tidal carbon dioxide FETCO2 is or becomes stable to changes in the patient's 12 delivered inspiratory time dTI. More specifically, this will identify the patient's 12 optimal inspiratory time TI-OPTIMAL. Preferably, the clinician and/or ventilator 16 will be able to determine this optimal inspiratory time TI-OPTIMAL within a few breaths of the patient 12 for any given inspiratory cycle. For example, when a stable end tidal carbon dioxide FETCO2 is reached, then preferred equilibration of carbon dioxide CO2 during a given delivered inspiratory time dTI can be achieved, as little or no more carbon dioxide CO2 can be effectively extracted from the patient's 12 blood by further increasing the patient's 12 delivered inspiratory time dTI. Accordingly, the patient's 12 optimal inspiratory time TI-OPTIMAL can then be ascertained and/or set.
  • [0084]
    More specifically, the patient's 12 end tidal carbon dioxide FETCO2 can be considered stable or more stable at or after a point A on a dTI response curve 150 in the figure (e.g., see a first portion 150 a of the dTI Response Curve 150) and non-stable or less stable or instable at or before that point A (e.g., see a second portion 150 b of the dTI Response Curve 150). Accordingly, the point A on the dTI Response Curve 150 can be used to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
  • [0085]
    Physiologically, when the patient's 12 end tidal carbon dioxide FETCO2 is equal to the patient's 12 capillary carbon dioxide FcCO2, diffusion stops and carbon dioxide CO2 extraction from the patient's 12 blood ceases. Ideally, the patient's 12 optimal inspiratory time TI-OPTIMAL is set where this diffusion becomes ineffective or stops. Otherwise, a smaller delivered inspiratory time dTI could suggest that additional carbon dioxide CO2 could be effectively removed from the patient's 12 blood, while a larger delivered inspiratory time dTI could suggest that no additional carbon dioxide CO2 could be effectively removed from the patient's 12 blood.
  • [0086]
    Preferably, finding the patient's 12 stable end tidal carbon dioxide FETCO2 occurs without interference from the patient's 12 blood chemistry sequelae. A preferred technique for finding the patient's 12 stable end tidal carbon dioxide FETCO2 can increase or decrease the patient's 12 inspiratory time dTI, which may minimally disrupt the patient's 12 blood reservoir of carbon dioxide CO2. Changes in the patient's 12 delivered inspiratory time dTI will affect how the patient's 12 blood buffers the patient's 12 carbon dioxide CO2, and if that blood circulates back to the patient's 12 lungs 30 before the patient's 12 set inspiratory time sTI is optimized, then the patient's 12 end tidal carbon dioxide FETCO2 will be different for a given inspiratory time dTI. At that point, optimizing the patient's 12 set inspiratory time sTI may become a dynamic process. In any event, the time available to find the patient's 12 optimal inspiratory time TI-OPTIMAL may be approximately one (1) minute for an average adult patient 12.
  • [0087]
    One way to decrease the likelihood of interference from the patient's 12 blood chemistry sequelae is to change the patient's 12 delivered inspiratory time dTI for two (2) or more inspirations, and then use the patient's 12 resulting end tidal carbon dioxide FETCO2 to extrapolate using an apriori function, such as an exponential function, by techniques known in the art.
  • [0088]
    For example, if the patient's 12 first end tidal carbon dioxide FETCO2 was originally determined at a point B on a dTI Response Curve 152 in the figure, and then at a point C, and then at a point D, and then at a point E, and then at a point F, and then at a point G, and then so on, then the data points (e.g., points B-G) could be collected and a best fit dTI Response Curve 152 obtained; extrapolating as needed. Preferably, the dTI Response Curve 152 is piecewise continuous. For example, a first portion 152 a of the dTI Response Curve 152 may comprise a stable horizontal or substantially horizontal portion (e.g., points B-D) while a second portion 152 b thereof may comprise a polynomial portion (e.g., points E-G). Where this first portion 152 a and second portion 152 b of the dTI Response Curve 152 intersect (e.g., see point A on the dTI Response Curve 152) can be used to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
  • [0089]
    For example, referring now to FIG. 9, an arrangement to identify the patient's 12 optimal inspiratory time TI-OPTIMAL based on an iterative process will be described. More specifically, one preferred arrangement for determining an optimal inspiratory time TI-OPTIMAL collects FETCO2 data in equal or substantially equal inspiratory time increments ΔTI. For example, if the patient's 12 first end tidal carbon dioxide FETCO2 was originally determined to be within the first portion 152 a of the dTI response curve 152 (e.g., see points B-D), then the clinician and/or ventilator 16 could decrease the patient's 12 delivered inspiratory times dTI until the patient's 12 end tidal carbon dioxide FETCO2 readings were within the second portion 152 b of the dTI response curve 152 (e.g., see points E-G).
  • [0090]
    For example, if the patient's 12 end tidal carbon dioxide FETCO2 was originally determined to be at point C on the dTI response curve 152 (i.e., within the first portion 152 a of the dTI response curve 152), then the patient's 12 delivered inspiratory time dTI could be decreased until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point D on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would still be determined to be within the first portion 152 a of the dTI response curve 152. Accordingly, the patient's 12 delivered inspiratory time dTI could be decreased again until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point E on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would now be determined to be within the second portion 152 b of the dTI response curve 152 (i.e., the patient's 12 end tidal carbon dioxide FETCO2 would have dropped and thus not be at the patient's 12 optimal inspiratory time TI-OPTIMAL). Accordingly, a smaller delivered inspiratory time increment ΔTI/x could be made to determine when the patient's 12 end tidal carbon dioxide FETCO2 was as at point A on the dTI response curve 152—i.e., at the intersection of the first portion 152 a of the dTI response curve 152 and the second portion 152 b of the dTI response curve 152. In this iterative fashion, successively smaller delivered time increments and/or decrements ΔTI are made to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
  • [0091]
    In like fashion, if the patient's 12 end tidal carbon dioxide FETCO2 was originally determined to be at point F on the dTI response curve 152 (i.e., within the second portion 152 b of the dTI response curve 152), then the patient's 12 delivered inspiratory time dTI could be increased until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point E on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would still be determined to be within the second portion 152 b of the dTI response curve 152. Accordingly, the patient's 12 delivered inspiratory time dTI could be increased again until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point D on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would now be determined to be within the first portion 152 a of the dTI response curve 152 (i.e., the patient's 12 end tidal carbon dioxide FETCO2 would not have increased and thus not be at the patient's 12 optimal inspiratory time TI-OPTIMAL). Accordingly, a smaller delivered inspiratory time decrement ΔTI/x could be made to determine when the patient's 12 end tidal carbon dioxide FETCO2 was as at point A on the dTI response curve 152—i.e., at the intersection of the first portion 152 a of the dTI response curve 152 and the second portion 152 b of the dTI response curve 152. In this iterative fashion, successively smaller delivered time increments and/or decrements ΔTI are again made to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
  • [0092]
    In addition, once the patient's 12 optimal inspiratory time TI-OPTIMAL is determined, it is realized this may be dynamic, by which the above arrangements can be repeated, as needed and/or desired.
  • [0093]
    Now then, a lower bound on the patient's 12 set inspiratory time sTI should be directly related to the minimal time required to deliver the patient's 12 minimal set tidal volume sVT.
  • [0094]
    A lower bound for the patient's 12 set and delivered tidal volume sVT, dVT should exceed VD, preferably within a predetermined and/or clinician-selected safety margin. Preferably, a re-arrangement of the Enghoff-Bohr equation can be used to find VD or the following variation:
  • [0000]
    V D = V T - V A = V T - V CO 2 F ET CO 2
  • [0095]
    After the patient's 12 end tidal carbon dioxide FETCO2 is determined, then the patient's 12 set tidal volume sVT can be set accordingly, but it may not yet be set at an optimal value. Often, the clinician and/or ventilator 16 will attempt to determine this desired value. For example, the clinician may consider the desired value as the patient's 12 pre-induction end tidal carbon dioxide FETCO2. The clinician can then adjust the patient's 12 set tidal volume sVT until the desired end tidal carbon dioxide FETCO2 is achieved. Alternatively, or in conjunction therewith, a predetermined methodology can also be used to adjust the patient's 12 delivered tidal volume dVT until the desired end tidal carbon dioxide FETCO2 is achieved. For example, such a methodology may use a linear method to achieve a desired end tidal carbon dioxide FETCO2.
  • [0096]
    Preferably, the clinician can be presented with a dialog box on the monitor 38, for example (see FIG. 1), indicating the current and/or updated optimal ventilator 16 settings to be accepted or rejected. Preferably, the settings can be presented to the clinician in the dialog box for acceptance or rejection, who can then accept them, reject them, and/or alter them before accepting them. Alternatively, the settings can also be automatically accepted, without employing such a dialog box.
  • [0097]
    As previously indicated, different techniques can also be used to search for optimal settings for the ventilator 16. If desired, the delivered values can also be periodically altered to assess whether, for example, the settings are still optimal. Preferably, these alterations can follow one or more of the methodologies outlined above, and they can be determined based on a predetermined and/or clinician-selected time interval, on demand by the physiological, and/or determined by other control parameters, based, for example, on clinical events, such as changes in the patient's 12 end tidal carbon dioxide FETCO2, or on clinical events such as changes in drug dosages, repositioning the patient, surgical events and the like. For example, the patient's 12 delivered inspiratory time dTI can vary about its current value set inspiratory time sTI and the resulting end tidal carbon dioxide FETCO2 can be compared to the current end tidal carbon dioxide FETCO2 to assess the optimality of the current settings. If, for example, a larger delivered inspiratory time dTI leads to a larger end tidal carbon dioxide FETCO2, then the current set inspiratory time sTI could be too small.
  • [0098]
    In an alternative embodiment, the dTI response curve 154 could be expressed in terms of VCO2 instead of FETCO2, as shown in FIG. 10. The morphology of the response curve 154 will be similar to that as shown in FIG. 9. Without loss of generality, the above techniques can be used to find TI-OPTIMAL utilizing VCO2 as opposed to FETCO2. The VCO2 is equal to the inner product over one breath between a volume curve and a CO2 curve. The flow and CO2 curves should be synchronized in time.
  • [0099]
    One representative summary of potential inputs to, and outputs from, such a methodology is depicted below:
  • [0000]
    Clinician Inputs The patient's 12 age, weight, height, gender, location,
    and/or desired FETCO2, etc.
    Measured Inputs End tidal carbon dioxide FETCO2, flow wave data, etc.
    Outputs The patient's 12 set expiratory time sTE, inspiratory
    time set, and/or set tidal volume sVT
  • [0100]
    In addition, by more closely aligning the patient's 12 set expiratory time sTE and the patient's 12 natural exhalation time TEXH during mandatory mechanical ventilation, mean alveolar ventilation increases. In addition, there is additional optimal carbon dioxide CO2 removal, improved oxygenation, and/or more anesthesia agent equilibration, whereby ventilated gas exchanges become more efficient with respect to use of lower set tidal volume sVT compared to conventional settings. Minute ventilations and respiratory resistance can be reduced, and reducing volumes can decrease the patient's 12 airway pressure Paw thereby reducing the risk of inadvertently over distending the lung.
  • [0101]
    In addition, the inventive arrangements facilitate ventilation for patients 12 with acute respiratory distress syndrome, and they can be used to improve usability during both single and double lung ventilations, as well transitions therebetween.
  • [0102]
    As a result of the foregoing, several of the inventive arrangements set the patient's 12 set expiratory time sTE equal to the time period between when the ventilator 16 permits the patient 12 to exhale and when the patient's 12 expiratory flow ceases—i.e., the patient's 12 natural exhalation time TEXH. This facilitates the patient's 12 breathing by ensuring that ventilated airflows are appropriate for that patient 12 at that time in the treatment. In addition, methods of setting optimal patient inspired time TI-OPTIMAL and desired tidal volume are presented.
  • [0103]
    It should be readily apparent that this specification describes illustrative, exemplary, representative, and non-limiting embodiments of the inventive arrangements. Accordingly, the scope of the inventive arrangements are not limited to any of these embodiments. Rather, various details and features of the embodiments were disclosed as required. Thus, many changes and modifications—as readily apparent to those skilled in these arts—are within the scope of the inventive arrangements without departing from the spirit hereof, and the inventive arrangements are inclusive thereof. Accordingly, to apprise the public of the scope and spirit of the inventive arrangements, the following claims are made:
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2414747 *Jul 2, 1942Jan 21, 1947Harry M KirschbaumMethod and apparatus for controlling the oxygen content of the blood of living animals
US2912979 *Feb 17, 1956Nov 17, 1959Lieber Samuel LoewensteinApparatus for administering and conserving gas
US3212496 *Aug 21, 1962Oct 19, 1965United Aircraft CorpMolecular physiological monitoring system
US3400712 *Aug 12, 1965Sep 10, 1968James E. FinanSystem for intermittently dispensing oxygen or other gas suitable for breathing
US3400713 *Oct 12, 1966Sep 10, 1968James E. FinanApparatus for intermittently dispensing oxygen or other gas suitable for breathing
US3493703 *Aug 2, 1968Feb 3, 1970James E FinanBody motion sensitive electrical switch with lost motion means
US3595226 *Jan 19, 1968Jul 27, 1971Air ReductionRegulated breathing system
US3621833 *Jun 26, 1969Nov 23, 1971Crane RobertMethod and apparatus for automatically determining physiological parameters related to human breathing airway resistance and functional residual capacity
US3734091 *Jun 22, 1971May 22, 1973Airco IncOxygen control system with blood oxygen saturation sensing means and method for closed system breathing
US3741208 *Feb 23, 1971Jun 26, 1973Ingelstedt SLung ventilator
US3835845 *Oct 24, 1972Sep 17, 1974Medical Innovations IncCardiac synchronization system and method
US3923055 *Nov 15, 1974Dec 2, 1975Hoffmann La RocheProcess and device for controlling the pressure course of a respirator
US3961627 *Sep 3, 1974Jun 8, 1976Hoffmann-La Roche Inc.Automatic regulation of respirators
US3972327 *Nov 7, 1974Aug 3, 1976Hoffmann-La Roche Inc.Respirator
US3976064 *Mar 11, 1975Aug 24, 1976Wood William WIntermittent mandatory assisted ventilation system for positive pressure breathing apparatus
US4016871 *Mar 6, 1975Apr 12, 1977Peter SchiffElectronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart
US4036221 *Apr 2, 1975Jul 19, 1977Sutter Hospitals Medical Research FoundationRespirator
US4050458 *Jan 26, 1976Sep 27, 1977Puritan-Bennett CorporationRespiration system with patient assist capability
US4054133 *Mar 29, 1976Oct 18, 1977The Bendix CorporationControl for a demand cannula
US4121578 *Oct 4, 1976Oct 24, 1978The Bendix CorporationPhysiological responsive control for an oxygen regulator
US4141356 *Nov 18, 1977Feb 27, 1979Bourns, Inc.Respirator system and method
US4163450 *Jan 27, 1977Aug 7, 1979Cramp Harvey EMethod and apparatus for weaning patient from continuous mechanical ventilation
US4176663 *Oct 4, 1977Dec 4, 1979National Research Development CorporationMedical ventilation apparatus
US4192001 *Dec 2, 1977Mar 4, 1980Francesco VillaDecompression ascent computer
US4204524 *Nov 7, 1977May 27, 1980Dov JaronMethod and apparatus for controlling cardiac assist device
US4256100 *Feb 12, 1979Mar 17, 1981Rule Medical Instruments, Inc.Flow control equipment
US4265237 *Jun 22, 1979May 5, 1981Dragerwerk AktiengesellschaftApparatus for enhancing a person's breathing and/or artificial respiration
US4278110 *Nov 13, 1979Jul 14, 1981Price Ernest HDemand responsive flow controller
US4281651 *Jul 30, 1979Aug 4, 1981Airco, Inc.Lung ventilator
US4323064 *Jun 1, 1979Apr 6, 1982Puritan-Bennett CorporationVolume ventilator
US4326513 *Jun 30, 1980Apr 27, 1982Dragerwerk AgPatient data controlled respiration system
US4333476 *Dec 15, 1978Jun 8, 1982Downing Jr Willis GComprehensive pulmonary measurement technique
US4336590 *May 1, 1980Jun 22, 1982IntertechniqueDevices for controlling gas flows
US4340044 *Mar 20, 1980Jul 20, 1982Berkshire Research PartnersVolume ventilator
US4351344 *Nov 13, 1980Sep 28, 1982Bio-Med Devices, Inc.Method and apparatus for monitoring lung compliance
US4380233 *Dec 30, 1980Apr 19, 1983SynthelaboControl device for an artificial respirator
US4381002 *Dec 18, 1980Apr 26, 1983The United States Of America As Represented By The Secretary Of The ArmyFluidic-controlled oxygen intermittent demand flow device
US4386604 *Feb 27, 1981Jun 7, 1983Daniel HersheyDetermination of the basal metabolic rate of humans with a whole-body calorimeter
US4413632 *Oct 9, 1979Nov 8, 1983Critikon, Inc.Pulmonary monitor
US4417573 *Jul 2, 1981Nov 29, 1983Bear Medical Systems, Inc.Patient adaptor for medical ventilator
US4421113 *Jun 2, 1981Dec 20, 1983Engstrom Medical AktiebolagMethod and apparatus for controlling lung ventilators
US4424806 *Mar 12, 1981Jan 10, 1984Physio-Control CorporationAutomated ventilation, CPR, and circulatory assistance apparatus
US4444201 *Aug 19, 1981Apr 24, 1984Tokyo Shibaura Denki Kabushiki KaishaRespiration monitoring apparatus and method
US4448192 *Mar 5, 1982May 15, 1984Hewlett Packard CompanyMedical ventilator device parametrically controlled for patient ventilation
US4450527 *Jun 29, 1982May 22, 1984Bomed Medical Mfg. Ltd.Noninvasive continuous cardiac output monitor
US4456008 *Sep 13, 1982Jun 26, 1984Clawson Burrell ERespiratory apparatus and method
US4457303 *Nov 26, 1980Jul 3, 1984Tritec Industries, Inc.Respirating gas supply control method and apparatus therefor
US4459982 *Sep 13, 1982Jul 17, 1984Bear Medical Systems, Inc.Servo-controlled demand regulator for respiratory ventilator
US4461293 *Dec 3, 1982Jul 24, 1984Kircaldie, Randall, And McnabRespirating gas supply method and apparatus therefor
US6190326 *Apr 23, 1999Feb 20, 2001Medtrac Technologies, Inc.Method and apparatus for obtaining patient respiratory data
US20020032387 *May 8, 1997Mar 14, 2002Jacob GevaApparatus and method for remote spirometry
US20020053345 *Oct 2, 2001May 9, 2002Jafari Mehdi M.Medical ventilator triggering and cycling method and mechanism
US20040134496 *Apr 21, 2003Jul 15, 2004Cho Yong K.Method and apparatus for detecting respiratory disturbances
US20050109340 *Sep 7, 2004May 26, 2005Tehrani Fleur T.Method and apparatus for controlling a ventilator
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8434479Feb 27, 2009May 7, 2013Covidien LpFlow rate compensation for transient thermal response of hot-wire anemometers
US8439036Dec 1, 2009May 14, 2013Covidien LpExhalation valve assembly with integral flow sensor
US8439037Dec 1, 2009May 14, 2013Covidien LpExhalation valve assembly with integrated filter and flow sensor
US8457706May 15, 2009Jun 4, 2013Covidien LpEstimation of a physiological parameter using a neural network
US8469030Dec 1, 2009Jun 25, 2013Covidien LpExhalation valve assembly with selectable contagious/non-contagious latch
US8469031Dec 1, 2009Jun 25, 2013Covidien LpExhalation valve assembly with integrated filter
US8800557Apr 1, 2010Aug 12, 2014Covidien LpSystem and process for supplying respiratory gas under pressure or volumetrically
US8905024Mar 12, 2013Dec 9, 2014Covidien LpFlow rate compensation for transient thermal response of hot-wire anemometers
US9144658Apr 30, 2012Sep 29, 2015Covidien LpMinimizing imposed expiratory resistance of mechanical ventilator by optimizing exhalation valve control
US9205221Apr 23, 2013Dec 8, 2015Covidien LpExhalation valve assembly with integral flow sensor
US9364624Dec 7, 2011Jun 14, 2016Covidien LpMethods and systems for adaptive base flow
US9498589Dec 31, 2011Nov 22, 2016Covidien LpMethods and systems for adaptive base flow and leak compensation
USD653749Apr 27, 2010Feb 7, 2012Nellcor Puritan Bennett LlcExhalation module filter body
USD655405Apr 27, 2010Mar 6, 2012Nellcor Puritan Bennett LlcFilter and valve body for an exhalation module
USD655809Apr 27, 2010Mar 13, 2012Nellcor Puritan Bennett LlcValve body with integral flow meter for an exhalation module
USD692556Mar 8, 2013Oct 29, 2013Covidien LpExpiratory filter body of an exhalation module
USD693001Mar 8, 2013Nov 5, 2013Covidien LpNeonate expiratory filter assembly of an exhalation module
USD701601Mar 8, 2013Mar 25, 2014Covidien LpCondensate vial of an exhalation module
USD731048Mar 8, 2013Jun 2, 2015Covidien LpEVQ diaphragm of an exhalation module
USD731049Mar 5, 2013Jun 2, 2015Covidien LpEVQ housing of an exhalation module
USD731065Mar 8, 2013Jun 2, 2015Covidien LpEVQ pressure sensor filter of an exhalation module
USD736905Mar 8, 2013Aug 18, 2015Covidien LpExhalation module EVQ housing
USD744095Mar 8, 2013Nov 24, 2015Covidien LpExhalation module EVQ internal flow sensor
USD775345Apr 10, 2015Dec 27, 2016Covidien LpVentilator console
CN104284691A *Apr 23, 2013Jan 14, 2015皇家飞利浦有限公司Systems and methods to determine the fraction of inhaled oxygen during ventilation.
Classifications
U.S. Classification128/204.21
International ClassificationA61M16/00
Cooperative ClassificationA61M16/00, A61M2230/40, A61M2230/43, A61M2230/205
European ClassificationA61M16/00
Legal Events
DateCodeEventDescription
Apr 4, 2007ASAssignment
Owner name: GENERAL ELECTRIC COMPANY, NEW YORK
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MITTON, MICHAEL PAUL;THAM, ROBERT QUINYEW;CHONCHOLAS, GARY JAMES;AND OTHERS;REEL/FRAME:019115/0178
Effective date: 20070314
Owner name: GENERAL ELECTRIC COMPANY,NEW YORK
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MITTON, MICHAEL PAUL;THAM, ROBERT QUINYEW;CHONCHOLAS, GARY JAMES;AND OTHERS;REEL/FRAME:019115/0178
Effective date: 20070314